Yıl: 2021 Cilt: 11 Sayı: 3 Sayfa Aralığı: 241 - 248 Metin Dili: İngilizce DOI: 10.4274/jarem.galenos.2021.82473 İndeks Tarihi: 21-05-2022

The PR Interval Predicted Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: 3 Years Follow-up Results

Öz:
Objective: It is crucial to identify the high-risk group in acute coronary syndrome (ACS) patients who underwent percutaneous coronary intervention (PCI). To date, various stratification tools have been developed to predict adverse events. However, the PR interval is a readily available parameter in routine clinical practice. This study aimed to investigate the role of the PR interval in predicting major adverse cardiovascular events (MACE) in patients with ACS who were performed PCI. Methods: Patients diagnosed with ACS and who underwent PCI between January 2015 and July 2018 were included in the study. Patients were followed up for an average of 3.2 years. Electrocardiogram was obtained from all patients on admission to the hospital. The PR interval was measured by the semi-automatic application tool. The primary outcome was all-cause mortality, new-onset decompensated heart failure, cerebrovascular event, and recurrent revascularization. Results: The mean age of total 177 ACS patients was 58.7±10.3 years and 150 (84.7%) of them were male. MACE developed in 38 patients (21.4%) who were older (p<0.001) with a male preponderance (p=0.032). The PR interval was shorter in the MACE (+) group than the MACE (-) group (154.2±21.2 vs 164.1±18.1 ms, p=0.004). Backward multivariable Cox regression analysis revealed that male gender [hazard ratio (HR)=3.667, 95% confidence interval (CI): 1.501-8.961, p=0.004], PR interval [HR=0.981, 95% CI:0.961-0.996, p=0.019], and left ventricular ejection fraction [HR=0.906, 95% CI:0.873-0.941, p<0.001] were independent predictors of MACE during long-term follow-up. Conclusion: The PR interval and male gender were independent predictors of long-term MACE in patients with ACS without atrioventricular conduction defect.
Anahtar Kelime:

Primer Perkütan Koroner Girişim Uygulanan Akut Koroner Sendrom Hastalarında PR Mesafesi Majör İstenmeyen Olayları Öngörmüştür: 3 Yıllık Takip SonuçlarıPrimer Perkütan Koroner Girişim Uygulanan Akut Koroner Sendrom Hastalarında PR Mesafesi Majör İsten

Öz:
Amaç: Akut koroner sendrom (AKS) hastalarında yüksek riskli grupları belirlemek önemlidir. Şimdiye kadar çeşitli sınıflandırma araçları geliştirilmiştir. PR intervali rutin günlük pratikte kolay elde edilebilir bir parametredir. Bu çalışmada perkütanöz koroner girişim (PCI) yapılmış AKS hastalarında PR mesafesinin uzun dönem majör istenmeyen advers olayları (MACE) öngörmedeki etkisini araştırmayı amaçladık. Yöntemler: Ocak 2017 ile Temmuz 2017 tarihleri arasında PCI uygulanan toplamda 177 AKS hastası çalışmaya dahil edildi. Ortalama 3,2 yıl boyunca hastalar takip edildi. Elektrokardiyografi verileri tüm hastalardan başvuru anında elde edildi ve yarı otomatik uygulama aracılığıyla PR aralıkları ölçüldü. Primer sonlanım noktası tüm sebeplere bağlı ölüm, yeni başlayan dekompanse kalp yetmezliği, serebrovasküler olay ve tekrarlayan revaskülarizasyon olarak belirlendi. Bulgular: Çalışmaya dahil edilen toplam 177 hastanın yaş ortalaması 58,7±10,3 yıl ve 150 (%84,7) kişi erkekti. Hastaların 38 tanesinde (%21,4) MACE gelişti ve bu grupta erkek cinsiyeti hakimiyeti olmakla beraber (p=0,032) daha yaşlı olduğu görüldü (p<0,001). PR intervali MACE (+) grubunda MACE (-) grubuna göre daha kısaydı (154,2±21,2 vs 164,1±18,1, p=0,004). Cox regresyon analizinde erkek cinsiyet [risk oranı (RO)=3,667, %95 güven aralığı (GA): 1,501-8,961, p=0,004], PR mesafesi [RO=0,981, 95% GA:0,961-0,996, p=0,019] ve sol ventrikül ejeksiyon fraksiyonu [RO=0,906, %95 GA: 0,873- 0,941, p<0,001] bağımsız MACE öngördürücüsüydü. Sonuç: Atriyoventriküler ileti kusuru olmayan AKS hastalarında PR mesafesi ve erkek cinsiyet uzun dönem istenmeyen olayların bağımsız öngördürücüsüdür.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Aguado-Romeo MJ, Márquez-Calderón S, Buzón-Barrera ML. Hospital mortality in acute coronary syndrome: differences related to gender and use of percutaneous coronary procedures. BMC Health Serv Res 2007; 7: 110.
  • 2. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003; 163: 2345-53.
  • 3. Lehmacher J, Neumann JT, Sörensen NA, Goßling A, Haller PM, Hartikainen TS, et al. Predictive value of serial ecgs in patients with suspected myocardial infarction. J Clin Med 2020; 9: 2303.
  • 4. Wang X, Zhang L, Gao C, Zhu J, Yang X. Tpeak-Tend/QT interval predicts ST-segment resolution and major adverse cardiac events in acute ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention. Medicine (Baltimore) 2018; 97: e12943. doi: 10.1097/MD.0000000000012943.
  • 5. Timóteo AT, Mendonça T, Aguiar Rosa S, Gonçalves A, Carvalho R, Ferreira ML, et al. Prognostic impact of bundle branch block after acute coronary syndrome. Does it matter if it is left of right? Int J Cardiol Heart Vasc 2019; 22: 31-4.
  • 6. Lévy S. Bundle branch blocks and/or hemiblocks complicating acute myocardial ischemia or infarction. J Interv Card Electrophysiol 2018; 52: 287-92.
  • 7. Wang SL, Wang CL, Wang PL, Xu H, Du JP, Zhang DW, et al. Resting heart rate associates with one-year risk of major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention. Exp Biol Med 2016; 241: 478-84.
  • 8. Palatini P. Heart rate and the cardiometabolic risk. Curr Hypertens Rep 2013; 15: 253-9.
  • 9. Kennedy A, Finlay DD, Guldenring D, Bond R, Moran K, McLaughlin J. The cardiac conduction system: generation and conduction of the cardiac ımpulse. Crit Care Nurs Clin North Am 2016; 28: 269-79.
  • 10. Atterhög JH, Loogna E. P-R interval in relation to heart rate during exercise and the influence of posture and autonomic tone. J Electrocardiol 1977; 10: 331-6.
  • 11. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol 2016; 68: 1082-115.
  • 12. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019; 40: 87-165.
  • 13. Levy MN. Cardiac sympathetic-parasympathetic interactions. Fed Proc 1984; 43: 2598-602.
  • 14. Kowallik P, Meesmann M. Independent autonomic modulation of the human sinus and AV nodes: evidence from beat-to-beat measurements of PR and PP intervals during sleep. J Cardiovasc Electrophysiol 1995; 6: 993-1003.
  • 15. Moreira HG, Lage RL, Martinez DG, Ferreira-Santos L, Rondon MUPB, Negrão CE, et al. Sympathetic nervous activity in patients with acute coronary syndrome: a comparative study
  • 16. Graham LN, Smith PA, Stoker JB, Mackintosh AF, Mary DA. Sympathetic neural hyperactivity and its normalization following unstable angina and acute myocardial infarction. Clin Sci (Lond). 2004 Jun;106(6):605-11.
  • 17. Xiong L, Liu Y, Zhou M, Wang G, Quan D, Shuai W, et al. Targeted ablation of cardiac sympathetic neurons attenuates adverse postinfarction remodelling and left ventricular dysfunction. Exp Physiol 2018; 103: 1221-9.
  • 18. Roshanzamir S, Showkathali R. Takotsubo cardiomyopathy a short review. Curr Cardiol Rev 2013; 9: 191-6.
  • 19. Gopinathannair R, Martins JB. Predicting sudden cardiac death in healthy humans: Is there more to autonomic balance than we know? Heart Rhythm 2008; 5: 306-7.
  • 20. Martínez-Milla J, Raposeiras-Roubín S, Pascual-Figal DA, Ibáñez B. Role of Beta-blockers in cardiovascular disease in 2019. Rev Esp Cardiol (Engl Ed) 2019; 72: 844-52. (English, Spanish)
  • 21. Grassi G, Esler M. How to assess sympathetic activity in humans. J Hypertens 1999; 17: 719-34.
  • 22. Kishi T. Heart rate is the clinical indicator of sympathetic activation and prognostic value of cardiovascular risks in patients with hypertension. Hypertension 2020; 76: 323-4.
  • 23. Skroza N, Mambrin A, Proietti I, Balduzzi V, Bernardini N, Marchesiello A, et al. Evaluation of cardiovascular risk in hidradenitis suppurativa patients using heart rate variability (HRV) analysis. Cardiovasc Ther 2020; 2020: 1321782. doi: 10.1155/2020/1321782.
  • 24. Martin P. The influence of the parasympathetic nervous system on atrioventricular conduction. Circ Res 1977; 41: 593-9.
  • 25. Chen LS, Zhou S, Fishbein MC, Chen PS. New perspectives on the role of autonomic nervous system in the genesis of arrhythmias. J Cardiovasc Electrophysiol 2007; 18: 123-7.
  • 26. Carruthers S, McCall B, Cordell B, Wu R. Relationships between heart rate
APA Yilmaz A, Çinier G, Kahraman F, Çetin M, Çırakoğlu Ö (2021). The PR Interval Predicted Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: 3 Years Follow-up Results. , 241 - 248. 10.4274/jarem.galenos.2021.82473
Chicago Yilmaz Ahmet Seyda,Çinier Göksel,Kahraman Fatih,Çetin Mustafa,Çırakoğlu Ömer Faruk The PR Interval Predicted Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: 3 Years Follow-up Results. (2021): 241 - 248. 10.4274/jarem.galenos.2021.82473
MLA Yilmaz Ahmet Seyda,Çinier Göksel,Kahraman Fatih,Çetin Mustafa,Çırakoğlu Ömer Faruk The PR Interval Predicted Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: 3 Years Follow-up Results. , 2021, ss.241 - 248. 10.4274/jarem.galenos.2021.82473
AMA Yilmaz A,Çinier G,Kahraman F,Çetin M,Çırakoğlu Ö The PR Interval Predicted Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: 3 Years Follow-up Results. . 2021; 241 - 248. 10.4274/jarem.galenos.2021.82473
Vancouver Yilmaz A,Çinier G,Kahraman F,Çetin M,Çırakoğlu Ö The PR Interval Predicted Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: 3 Years Follow-up Results. . 2021; 241 - 248. 10.4274/jarem.galenos.2021.82473
IEEE Yilmaz A,Çinier G,Kahraman F,Çetin M,Çırakoğlu Ö "The PR Interval Predicted Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: 3 Years Follow-up Results." , ss.241 - 248, 2021. 10.4274/jarem.galenos.2021.82473
ISNAD Yilmaz, Ahmet Seyda vd. "The PR Interval Predicted Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: 3 Years Follow-up Results". (2021), 241-248. https://doi.org/10.4274/jarem.galenos.2021.82473
APA Yilmaz A, Çinier G, Kahraman F, Çetin M, Çırakoğlu Ö (2021). The PR Interval Predicted Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: 3 Years Follow-up Results. JAREM, 11(3), 241 - 248. 10.4274/jarem.galenos.2021.82473
Chicago Yilmaz Ahmet Seyda,Çinier Göksel,Kahraman Fatih,Çetin Mustafa,Çırakoğlu Ömer Faruk The PR Interval Predicted Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: 3 Years Follow-up Results. JAREM 11, no.3 (2021): 241 - 248. 10.4274/jarem.galenos.2021.82473
MLA Yilmaz Ahmet Seyda,Çinier Göksel,Kahraman Fatih,Çetin Mustafa,Çırakoğlu Ömer Faruk The PR Interval Predicted Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: 3 Years Follow-up Results. JAREM, vol.11, no.3, 2021, ss.241 - 248. 10.4274/jarem.galenos.2021.82473
AMA Yilmaz A,Çinier G,Kahraman F,Çetin M,Çırakoğlu Ö The PR Interval Predicted Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: 3 Years Follow-up Results. JAREM. 2021; 11(3): 241 - 248. 10.4274/jarem.galenos.2021.82473
Vancouver Yilmaz A,Çinier G,Kahraman F,Çetin M,Çırakoğlu Ö The PR Interval Predicted Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: 3 Years Follow-up Results. JAREM. 2021; 11(3): 241 - 248. 10.4274/jarem.galenos.2021.82473
IEEE Yilmaz A,Çinier G,Kahraman F,Çetin M,Çırakoğlu Ö "The PR Interval Predicted Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: 3 Years Follow-up Results." JAREM, 11, ss.241 - 248, 2021. 10.4274/jarem.galenos.2021.82473
ISNAD Yilmaz, Ahmet Seyda vd. "The PR Interval Predicted Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: 3 Years Follow-up Results". JAREM 11/3 (2021), 241-248. https://doi.org/10.4274/jarem.galenos.2021.82473